Week in Review
Adventrx Pharmaceuticals Inc. raised $17 million in a public offering of stock and warrants.
Agios Pharmaceuticals Inc. raised $78 million in a Series C financing.
Allena Pharmaceuticals Inc. raised $15 million in a Series A round for nonsystemic oral proteins.
Athersys Inc. entered a $20 million standby equity purchase agreement with Aspire Capital Fund LLC.
Cadence Pharmaceuticals Inc. is raising $71.25 million in a public stock offering.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter